Price target
8.560.000.00%
The 4 analysts offering 1 year price forecasts for A2ACV2 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 4 analysts giving stock ratings to A2ACV2 in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
A2ACV2 EPS for the last quarter is EUR despite the estimation of −0.03 EUR. In the next quarter EPS is expected to reach −0.03 EUR. Track more of Oryzon Genomics SA financials and stay on top of what is up with the company.
In the next quarter Oryzon Genomics SA revenue is expected to reach 0.00 EUR. Check out Oryzon Genomics SA revenue and earnings and make informed decisions.
According to analysts, A2ACV2 price target is 8.56 EUR with a max estimate of 12.00 EUR and a min estimate of 4.35 EUR. Check if this forecast comes true in a year, meanwhile watch Oryzon Genomics SA stock price chart and keep track of the current situation with A2ACV2 news and stock market news.